OncoImmunity
Business Services · Norway · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Ullernchausséen 64, Oslo, Oslo, 0379, No...Phone Number
+47 90015242Website
www.oncoimmunity.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About OncoImmunity
NEC Bio B.V. is dedicated to developing innovative therapies for patients worldwide, utilizing advanced AI technologies. The company focuses on personalized cancer vaccines and next-generation vaccines for infectious diseases, employing strategies that target specific tumor antigens and immunogenic pathogens. Their research includes collaborations with various partners to enhance cancer immunotherapy and vaccine development. NEC Bio's pipeline features proprietary technologies aimed at improving patient outcomes in oncology and infectious disease treatment.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OncoImmunity your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
OncoImmunity, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if OncoImmunity had a recent Job posting/layoffs
Funding: Get notified immidiatlly once OncoImmunity has new funding data
Product Launch: Get notified when OncoImmunity launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if OncoImmunity is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on OncoImmunity recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at OncoImmunity
Check if OncoImmunity has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at OncoImmunity
Find more new buyers
Company Profile Activity
Activity Insights
OncoImmunity is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
OncoImmunity is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about OncoImmunity.
OncoImmunity Tech Stack
A closer look at the technologies used by OncoImmunity
OncoImmunity News & Media
NEC OncoImmunity Publishes a Unique HLA Typing Technology That Discovers New HLA Alleles, and Tumor Specific HLA Alleles
OSLO, Norway--(BUSINESS WIRE)-- #HLA--NEC OncoImmunity AS (NOI) today announced a publication that describes a novel approach to type new HLA alleles and characterize the HLA of tumors to guide personalized cancer immunotherapy. The computational approach performs HLA typing from next generation sequencing data by using the current strengths of conventional HLA typing while simultaneously allowing for the discovery of novel HLA alleles and tumor-specific HLA variants, through leveraging proprietNEC Acquires Bioinformatics Company OncoImmunity AS
NEC Corporation (NEC; TOKYO: 6701) acquired OncoImmunity AS, a Norway-based bioinformatics company that develops proprietary machine learning software to support the fight against cancer. The amount of the deal was not disclosed. Founded in 2014 and led by Dr. Richard Stratford, Chief Executive Officer, OncoImmunity is a bioinformatics company dedicated to the development of software […] The post NEC Acquires Bioinformatics Company OncoImmunity AS appeared first on FinSMEs.NEC Acquires Norwegian Bioinformatics Company, OncoImmunity AS
TOKYO--(BUSINESS WIRE)--NEC Corporation (NEC; TOKYO: 6701) today announced the acquisition of OncoImmunity AS, a Norway-based bioinformatics company that develops proprietary machine learning software to support the fight against cancer. OncoImmunity AS will now become a subsidiary of NEC and operate under the name of NEC OncoImmunity AS. OncoImmunity AS, founded in 2014, is a bioinformatics company dedicated to the development of software solutions that facilitate the effective selection of paFlow Pharma, Inc. and OncoImmunity AS partner for the Development of FlowVaxTM Personalized Cancer Vaccines
OSLO, Norway--(BUSINESS WIRE)--#neoantigen--Flow Pharma Inc., a San Francisco Bay Area biotechnology company focused on developing personalized cancer vaccines, today announced a collaboration with Norwegian bioinformatics company OncoImmunity AS. Under the agreement OncoImmunity will license the Immuneoprofiler™ software to Flow Pharma to support the clinical development and commercialisation of products based on the FlowVax platform. The Immuneoprofiler™ has recently received the CE-IVD mark c
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OncoImmunity
Sign Up For FreeTo access detailed company insights
NEC Bio B.V. is dedicated to developing innovative therapies for patients worldwide, utilizing advanced AI technologies. The company focuses on personalized cancer vaccines and next-generation vaccines for infectious diseases, employing strategies that target specific tumor antigens and immunogenic pathogens. Their research includes collaborations... Read More
